Pacific Biosciences of California COO Mark Van Oene's 2021 pay jumps 772% to $28M

Pacific Biosciences of California reports 2021 executive compensation

By ExecPay News

Published: April 14, 2022

Pacific Biosciences of California reported fiscal year 2021 executive compensation information on April 14, 2022.

In 2021, five executives at Pacific Biosciences of California received on average a compensation package of $9.5M, a 66% increase compared to previous year.

Average pay of disclosed executives at Pacific Biosciences of California

Mark Van Oene, Chief Operating Officer, received $28M in total. 53% of Van Oene's compensation, or $15M, was in option awards. Van Oene also received $200K in bonus, $376K in non-equity incentive plan, $540K in salary, as well as $12M in stock awards.

For fiscal year 2021, the median employee pay was $257,461 at Pacific Biosciences of California. Therefore, the ratio of Mark Van Oene's pay to the median employee pay was 110 to one.

Peter Fromen, Chief Commercial Officer, received a compensation package of $13M. 48% of the compensation package, or $6.4M, was in option awards.

Christian O. Henry, Chief Executive Officer, earned $2.9M in 2021, a 77% decrease compared to previous year.

Denis Zaccarin, Senior Vice President, Product Development, received $1.5M in 2021, which increases by 108% compared to 2020.

Susan G. Kim, Chief Financial Officer, earned $1.3M in 2021, a 67% decrease compared to previous year.